Arnaud Besson, Ph.D. - Publications

Affiliations: 
University of Calgary (Canada) 
Area:
Multiple Sclerosis

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Jungas T, Besson A, Davy A. EPH-ective control of cytokinesis. Cell Cycle (Georgetown, Tex.). 0. PMID 27786587 DOI: 10.1080/15384101.2016.1251230  0.36
2016 Jungas T, Perchey RT, Fawal M, Callot C, Froment C, Burlet-Schiltz O, Besson A, Davy A. Eph-mediated tyrosine phosphorylation of citron kinase controls abscission. The Journal of Cell Biology. PMID 27551053 DOI: 10.1083/jcb.201602057  0.36
2016 Duquesnes N, Callot C, Jeannot P, Daburon V, Nakayama KI, Manenti S, Davy A, Besson A. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome. The Journal of Pathology. PMID 27015986 DOI: 10.1002/path.4721  0.36
2014 Agarwal A, Mackenzie RJ, Besson A, Jeng S, Carey A, LaTocha DH, Fleischman AG, Duquesnes N, Eide CA, Vasudevan KB, Loriaux MM, Firpo E, Cortes JE, McWeeney S, O'Hare T, et al. BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein. Blood. 124: 3260-73. PMID 25293778 DOI: 10.1182/blood-2013-04-497040  1
2014 Gui P, Labrousse A, Van Goethem E, Besson A, Maridonneau-Parini I, Le Cabec V. Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration. Journal of Cell Science. 127: 4009-23. PMID 25015295 DOI: 10.1242/jcs.150987  1
2012 Godin JD, Thomas N, Laguesse S, Malinouskaya L, Close P, Malaise O, Purnelle A, Raineteau O, Campbell K, Fero M, Moonen G, Malgrange B, Chariot A, Metin C, Besson A, et al. p27(Kip1) is a microtubule-associated protein that promotes microtubule polymerization during neuron migration. Developmental Cell. 23: 729-44. PMID 23022035 DOI: 10.1016/j.devcel.2012.08.006  1
2012 Leclercq B, Besson A. [A new function for p27(KIP1) in mitosis]. MéDecine Sciences : M/S. 28: 570-2. PMID 22805127 DOI: 10.1051/medsci/2012286004  1
2012 Serres MP, Kossatz U, Chi Y, Roberts JM, Malek NP, Besson A. p27(Kip1) controls cytokinesis via the regulation of citron kinase activation. The Journal of Clinical Investigation. 122: 844-58. PMID 22293177 DOI: 10.1172/JCI60376  1
2012 Pippa R, Espinosa L, Gundem G, García-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C, Besson A, Pujol MJ, López-Bigas N, Paramio JM, Bigas A, Bachs O. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene. 31: 4207-20. PMID 22179826 DOI: 10.1038/onc.2011.582  1
2011 Serres MP, Zlotek-Zlotkiewicz E, Concha C, Gurian-West M, Daburon V, Roberts JM, Besson A. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene. 30: 2846-58. PMID 21317921 DOI: 10.1038/onc.2011.9  1
2010 Dalvai M, Schubart K, Besson A, Matthias P. Oct1 is required for mTOR-induced G1 cell cycle arrest via the control of p27(Kip1) expression. Cell Cycle (Georgetown, Tex.). 9: 3933-44. PMID 20935455 DOI: 10.4161/cc.9.19.13154  1
2010 Concha C, Besson A. p27Kip1 is needed...for glioma invasion. Cell Cycle (Georgetown, Tex.). 9: 1457. PMID 20421714  1
2009 Serres MP, Besson A. [Critical role for p27 in mediating the antitumoral activity of a proteasome inhibitor]. MéDecine Sciences : M/S. 25: 213-4. PMID 19361375 DOI: 10.1051/medsci/2009253213  1
2008 Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Developmental Cell. 14: 159-69. PMID 18267085 DOI: 10.1016/j.devcel.2008.01.013  1
2007 Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. [p27Kip1 independently promotes neuronal differentiation and migration in the cerebral cortex]. Bulletin Et MéMoires De L'AcadéMie Royale De MéDecine De Belgique. 162: 310-4. PMID 18405000  1
2007 Besson A. [p27Kip1: tumor suppressor and oncogene?]. MéDecine Sciences : M/S. 23: 1089-91. PMID 18154709 DOI: 10.1051/medsci/200723121089  1
2007 Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D, Clurman BE, Dyer MA, Roberts JM. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes & Development. 21: 1731-46. PMID 17626791 DOI: 10.1101/gad.1556607  1
2006 Nguyen L, Besson A, Roberts JM, Guillemot F. Coupling cell cycle exit, neuronal differentiation and migration in cortical neurogenesis. Cell Cycle (Georgetown, Tex.). 5: 2314-8. PMID 17102618  1
2006 Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes & Development. 20: 1511-24. PMID 16705040 DOI: 10.1101/gad.377106  1
2006 Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes & Development. 20: 47-64. PMID 16391232 DOI: 10.1101/gad.1384406  1
2004 Besson A, Assoian RK, Roberts JM. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nature Reviews. Cancer. 4: 948-55. PMID 15573116 DOI: 10.1038/nrc1501  1
2004 Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes & Development. 18: 862-76. PMID 15078817 DOI: 10.1101/gad.1185504  1
2003 Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, Goodyer CG, Rewcastle B, Yong VW. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4034-43. PMID 12764090  1
2002 Besson A, Wilson TL, Yong VW. The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. The Journal of Biological Chemistry. 277: 22073-84. PMID 11934885 DOI: 10.1074/jbc.M111644200  0.56
2001 Corley SM, Ladiwala U, Besson A, Yong VW. Astrocytes attenuate oligodendrocyte death in vitro through an alpha(6) integrin-laminin-dependent mechanism. Glia. 36: 281-94. PMID 11746766 DOI: 10.1002/glia.1116  1
2001 Besson A, Davy A, Robbins SM, Yong VW. Differential activation of ERKs to focal adhesions by PKC epsilon is required for PMA-induced adhesion and migration of human glioma cells. Oncogene. 20: 7398-407. PMID 11704869 DOI: 10.1038/sj.onc.1204899  1
2001 Besson A, Yong VW. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. Journal of Neuro-Oncology. 51: 245-64. PMID 11407596 DOI: 10.1023/A:1010657030494  1
2000 Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, Yong VW. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. Journal of Neuroscience Research. 61: 212-24. PMID 10878594 DOI: 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9  1
2000 Besson A, Yong VW. Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression. Molecular and Cellular Biology. 20: 4580-90. PMID 10848585 DOI: 10.1128/MCB.20.13.4580-4590.2000  1
1999 Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. European Journal of Biochemistry / Febs. 263: 605-11. PMID 10469123 DOI: 10.1046/j.1432-1327.1999.00542.x  1
Show low-probability matches.